Role of Temozolomide Regimen on Survival Outcomes in Molecularly Stratified WHO Grade II Gliomas: A Systematic Review

OBJECTIVE/INTRODUCTION: Although a critical chemotherapeutic, temozolomide's optimal regimen for 2016 World Health Organization (WHO) Grade II gliomas remains elusive, hence there is utility in not only cataloging survival outcomes of Grade II glioma subtypes against the background of temozolom...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghaffari-Rafi, Arash, Ghaffari-Rafi, Shadeh, Leon-Rojas, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202389/
https://www.ncbi.nlm.nih.gov/pubmed/34211862
http://dx.doi.org/10.4103/ajns.AJNS_186_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202389/
https://www.ncbi.nlm.nih.gov/pubmed/34211862
http://dx.doi.org/10.4103/ajns.AJNS_186_20

Ejemplares similares